Gyrodyne LLC (NASDAQ:GYRO) Sees Large Increase in Short Interest

Gyrodyne LLC (NASDAQ:GYRO) was the recipient of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 400 shares, a growth of 300.0% from the July 31st total of 100 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 600 shares, the days-to-cover ratio is presently 0.7 days.

Shares of NASDAQ GYRO traded down $0.39 during mid-day trading on Wednesday, hitting $19.60. The stock had a trading volume of 574 shares, compared to its average volume of 1,851. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.54 and a quick ratio of 2.54. The company has a 50 day moving average of $18.61 and a two-hundred day moving average of $18.84. Gyrodyne has a twelve month low of $16.76 and a twelve month high of $21.16.

An institutional investor recently raised its position in Gyrodyne stock. Gabelli Funds LLC grew its position in Gyrodyne LLC (NASDAQ:GYRO) by 15.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 44,164 shares of the real estate investment trust’s stock after purchasing an additional 6,049 shares during the period. Gabelli Funds LLC owned approximately 2.98% of Gyrodyne worth $795,000 at the end of the most recent quarter. 33.30% of the stock is currently owned by institutional investors.

About Gyrodyne

Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.

Further Reading: How Do Mutual Funds Work?

Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.